placeholder image
C. N. McMahill-Walraven All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United States. 
    Journal of managed care & specialty pharmacy. 2024
  • Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort study. 
    BMJ Med. 2023
  • Association of COVID-19 vs influenza with risk of arterial and venous thrombotic events among hospitalized patients. 
    JAMA. 2022
  • Patient characteristics, pain treatment patterns, and incidence of total joint replacement in a US population with osteoarthritis. 
    BMC Musculoskeletal Disorders. 2022
  • Using the IMEDS distributed database for epidemiological studies in type 2 diabetes mellitus. 
    BMJ open diabetes research & care. 2022
  • Descriptive analysis of long- and intermediate-acting insulin and key safety outcomes in adults with type 2 diabetes mellitus. 
    Journal of managed care & specialty pharmacy. 2019
  • Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to evaluate patterns of care. 
    Journal of managed care & specialty pharmacy. 2019
    • Contact
    full name
  • C. N. McMahill-Walraven
  • C. N. McMahill Walraven
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration